At the European Hematology Association (EHA) 2024 Hybrid Congress, the data from InnoCare’s (HKEX: 09969; SSE: 688428) robust pipelines were presented, showcasing significant advancements in various areas of hematology research and treatment. About InnoCare:InnoCare (HKEX: 09969; SSE: 688428) is a…
A recent survey conducted by Miracle-Ear, an Amplifon company, delved into the impact of hearing loss on the Gen X and Baby Boomer populations, aged 44 to 78. With data from 1,000 U.S. adults, the survey highlights significant findings regarding…
A recent study of Phoenix’s bioscience ecosystem has pinpointed three areas poised for significant growth and global impact, centered around the Phoenix Bioscience Core and surrounding regional hubs of research and innovation. The report, titled “Leveraging the Phoenix Region’s Bioscience…
Ideal Living, known for its AmazingAir and AquaTru products, will be showcasing at the Health Optimisation Summit in London’s Business Design Centre from June 15-16. This global event gathers experts in biohacking, nutrition, fitness, and preventative medicine to share insights.…
RedSail Technologies, a top provider of pharmacy solutions, has received a strategic growth investment from Leonard Green & Partners (LGP). Additionally, Francisco Partners (FP), the company’s creator through the merging of two divisions in 2020, will reinvest alongside management. This…
AVAVA, Inc., a pioneering medical aesthetics platform company developing safe and effective image-guided intradermal laser products for all skin tones, has secured $35 million in new financing. AVAVA, Inc. has successfully concluded its Series C funding round, securing $25 million…
“Pfizer’s Phase 3 Study on Duchenne Muscular Dystrophy Gene Therapy Falls Short of Primary Endpoint” Pfizer Inc. (NYSE: PFE) has reported that its CIFFREO Phase 3 trial, which evaluated the investigational mini-dystrophin gene therapy, fordadistrogene movaparvovec, in ambulatory Duchenne muscular…
Bristol Myers Squibb (NYSE: BMY) has announced that the U.S. Food and Drug Administration (FDA) granted accelerated approval to Augtyro™ (repotrectinib) for treating adult and pediatric patients aged 12 and above with solid tumors harboring a neurotrophic tyrosine receptor kinase…
Agenus has announced groundbreaking results from a clinical trial, published in Nature Medicine, showcasing the potential of a novel immunotherapy combination for treating microsatellite stable metastatic colorectal cancer (MSS mCRC), a type of cancer typically resistant to immunotherapy. This research,…
AstraZeneca’s FARXIGA® (dapagliflozin) has received approval from the US Food and Drug Administration (FDA) for improving glycemic control in pediatric patients with type-2 diabetes (T2D) aged 10 years and older. This approval follows positive results from the pediatric T2NOW Phase…
Siemens Healthineers has introduced the Biograph Trinion, a cutting-edge positron emission tomography/computed tomography (PET/CT) scanner renowned for its high performance, energy efficiency, and wide-ranging clinical capabilities, all while maintaining a low lifetime operational cost. James Williams, PhD, Head of Molecular…
One of the nation’s foremost healthcare providers, HCA Healthcare, has announced a significant contribution from the HCA Healthcare Foundation. Over the next three years, the Foundation will donate $1 million to the Consortium of Florida Education Foundations (Consortium) to support…